GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (FRA:TE1) » Definitions » Cyclically Adjusted Book per Share

Bio-Techne (FRA:TE1) Cyclically Adjusted Book per Share : €9.76 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Bio-Techne Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Techne's adjusted book value per share for the three months ended in Mar. 2025 was €11.908. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €9.76 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Bio-Techne's average Cyclically Adjusted Book Growth Rate was 8.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 12.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Techne was 32.30% per year. The lowest was 9.20% per year. And the median was 13.20% per year.

As of today (2025-05-28), Bio-Techne's current stock price is €42.40. Bio-Techne's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €9.76. Bio-Techne's Cyclically Adjusted PB Ratio of today is 4.34.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 4.41. And the median was 7.95.


Bio-Techne Cyclically Adjusted Book per Share Historical Data

The historical data trend for Bio-Techne's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Cyclically Adjusted Book per Share Chart

Bio-Techne Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.31 5.82 7.70 8.31 9.19

Bio-Techne Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.02 9.19 8.91 9.96 9.76

Competitive Comparison of Bio-Techne's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Bio-Techne's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Cyclically Adjusted PB Ratio falls into.


;
;

Bio-Techne Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Techne's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=11.908/134.9266*134.9266
=11.908

Current CPI (Mar. 2025) = 134.9266.

Bio-Techne Quarterly Data

Book Value per Share CPI Adj_Book
201506 5.078 100.684 6.805
201509 5.020 100.392 6.747
201512 5.284 99.792 7.144
201603 5.148 100.470 6.914
201606 5.252 101.688 6.969
201609 5.347 101.861 7.083
201612 5.657 101.863 7.493
201703 5.685 102.862 7.457
201706 5.656 103.349 7.384
201709 5.382 104.136 6.973
201712 5.626 104.011 7.298
201803 5.715 105.290 7.324
201806 6.140 106.317 7.792
201809 6.288 106.507 7.966
201812 6.385 105.998 8.128
201903 6.707 107.251 8.438
201906 6.798 108.070 8.487
201909 6.999 108.329 8.717
201912 7.778 108.420 9.680
202003 7.663 108.902 9.494
202006 7.974 108.767 9.892
202009 7.914 109.815 9.724
202012 8.068 109.897 9.906
202103 8.321 111.754 10.046
202106 8.325 114.631 9.799
202109 8.870 115.734 10.341
202112 9.583 117.630 10.992
202203 9.912 121.301 11.025
202206 10.278 125.017 11.093
202209 11.271 125.227 12.144
202212 10.979 125.222 11.830
202303 11.218 127.348 11.886
202306 11.514 128.729 12.068
202309 11.821 129.860 12.282
202312 11.458 129.419 11.946
202403 11.762 131.776 12.043
202406 12.148 132.554 12.365
202409 12.128 133.029 12.301
202412 12.570 133.157 12.737
202503 11.908 134.927 11.908

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Bio-Techne  (FRA:TE1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Techne's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=42.40/9.76
=4.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 4.41. And the median was 7.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Techne Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Techne Business Description

Industry
Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines